Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sinovac Granted SFDA Approval for Avian Flu Vaccine

publication date: Apr 2, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech Ltd. received approval from the SFDA for Panflu, a vaccine for H5N1 pandemic avian flu. Panflu is a whole viron inactivated vaccine, the only avian flu vaccine thus far to be granted approval in any country. Sinovac said the vaccine was approved only for stockpiling in the national program and would not be marketed to the general population. More details...

Stock Symbol: (AMEX:SVA)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



ChinaBio® Events
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors